ClariMed Inc. Strengthens Market Position with Strategic Acquisition

ClariMed Inc. Strengthens Market Position with Strategic Acquisition

We Are Human's Expert Team and Atlanta-Based Usability Lab Join ClariMed's Growing Network; Founder Annmarie Nicolson Appointed as Principal

ClariMed, Inc., a global leader in human-centered medical device development and regulatory services, has announced a significant acquisition of We Are Human, a consultancy based in the UK and US. Known for its user-focused design expertise in MedTech innovation, this acquisition promises to bring ClariMed's services and innovation closer to a wider audience.

Expanding Geographic Reach and Expertise

The acquisition expands ClariMed's footprint into the Southeast, where We Are Human's state-of-the-art research facility in Atlanta will enhance ClariMed's capabilities. This strategic move aligns with ClariMed's commitment to making transformative, human-centered medical technologies accessible to diverse communities.

Annmarie Nicolson, the founder of We Are Human, will be stepping into the role of Principal within ClariMed. Her extensive experience in early-stage research, user experience (UX), and contextual inquiry in MedTech will play a vital role in the leadership team as they seek to drive innovation further.

Vision for User-Centered Innovation

As expressed by ClariMed's CEO, Kelley Kendle, this acquisition signifies a deeper alignment of values and a commitment to a user-centered approach in medical technology. Kendle stated, “Our regional presence allows us to better meet the needs of our patients and advance our mission to make medical technology safer and more intuitive.” This merger not only strengthens their service offerings but also enhances how they address patient needs.

Elevating Standards in Medical Device Services

With the inclusion of We Are Human's team and research acumen, ClariMed is positioned as a premier integrated medical device services partner. The newly formed team brings ISO 13485 certification along with significant knowledge of IEC-62366 and FDA regulatory standards. They have a proven track record of successful research engagements with diverse healthcare professionals and patients alike, demonstrating an unwavering commitment to excellence and user-centered solutions.

The Atlanta facility serves as ClariMed's latest research hub, providing access to varied study populations in the Southeast, thus enhancing the company’s ability to cater to an expanding client base.

Shared Commitment to Healthcare Excellence

Regarding the integration, Nicolson commented, “Joining ClariMed represents an exciting opportunity for us to amplify our impact in healthcare through human-centered research and design.” Both ClariMed and We Are Human are bound by their dedication to prioritizing user needs in their solution development, positioning themselves to deliver meaningful outcomes for clients and healthcare providers dependent on innovative medical technologies.

Strengthening Global Presence

This acquisition marks ClariMed's inaugural location in the Southeast, complementing their existing offices across the United States and internationally, including locations such as Chadds Ford, PA; Cambridge, MA; San Jose, CA; Cambridge, UK; and Leeds, UK. By expanding their geographic presence, ClariMed enhances their ability to cater to global clientele, tapping into diverse talent pools that will enrich their user research and usability testing processes.

ClariMed remains steadfast in its growth strategy, focusing on comprehensive human-centered solutions for medical device development. The merger amplifies ClariMed's capacity to meet the needs of pharmaceutical and medical device manufacturers as they strive to expedite product time to market, improve patient safety, and enhance user experience.

About ClariMed

ClariMed is a leading development and regulatory practice dedicated to human-centered medical products created by pharmaceutical and medical device manufacturers. Their approach emphasizes innovation alongside the safe and effective use of medical products. With offices spread across the United States and the United Kingdom, ClariMed offers thorough, integrated solutions that place human factors at the heart of device development and regulatory processes.

About We Are Human

Founded with a mission to prioritize human needs in design, We Are Human specializes in Human Factors, User Research, and UX, ensuring enhanced quality of life and health through product development. This ISO 13485 certified consultancy excels in user-centered research and design, demonstrating its expertise through collaboration with clients across a wide spectrum of products, fulfilling regulatory requirements effectively.

Frequently Asked Questions

What does the acquisition of We Are Human by ClariMed entail?

The acquisition allows ClariMed to expand its services and reach in the Southeast market through We Are Human's expertise in user-focused design and MedTech research.

How does this acquisition benefit ClariMed?

This acquisition enhances ClariMed's capabilities in user experience research and regulatory compliance, allowing it to better serve the healthcare community and clients.

Who is Annmarie Nicolson?

Annmarie Nicolson is the founder of We Are Human and will assume the role of Principal at ClariMed, leveraging her extensive experience in healthcare user-centered design.

What are ClariMed's future plans post-acquisition?

ClariMed plans to utilize We Are Human's expertise to enhance its offerings and innovate medical technologies that are safe and effective for users and patients.

Why is user-centered design important in healthcare?

User-centered design ensures that medical technologies meet the actual needs of patients, which can improve overall health outcomes and enhance user satisfaction.

About The Author

Riley Hayes here, a financial writer and specialist committed to assisting individuals in navigating the intricate world of finance. My love is using my blog and articles to simplify complex financial ideas into understandable, doable guidance. Having worked in finance for many years, I try to give my readers the information and resources they need to make wise financial choices.

Writing for several financial blogs has let me connect with a wide range of readers, from novice investors seeking new ideas to seasoned investors. My mission is to make money interesting and approachable so you may take charge of your financial future. I appreciate you traveling with me toward success and financial literacy.

Contact Riley Hayes privately here. Or send an email with ATTN: Riley Hayes as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.